120 related articles for article (PubMed ID: 16935586)
1. Risk factors for five-year incident age-related macular degeneration: the Reykjavik Eye Study.
Arnarsson A; Sverrisson T; Stefánsson E; Sigurdsson H; Sasaki H; Sasaki K; Jonasson F
Am J Ophthalmol; 2006 Sep; 142(3):419-28. PubMed ID: 16935586
[TBL] [Abstract][Full Text] [Related]
2. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study.
Klein R; Klein BE; Knudtson MD; Meuer SM; Swift M; Gangnon RE
Ophthalmology; 2007 Feb; 114(2):253-62. PubMed ID: 17270675
[TBL] [Abstract][Full Text] [Related]
3. 5-year incidence of age-related maculopathy in the Reykjavik Eye Study.
Jonasson F; Arnarsson A; Peto T; Sasaki H; Sasaki K; Bird AC
Ophthalmology; 2005 Jan; 112(1):132-8. PubMed ID: 15629833
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study.
Tan JS; Mitchell P; Smith W; Wang JJ
Ophthalmology; 2007 Jun; 114(6):1143-50. PubMed ID: 17275090
[TBL] [Abstract][Full Text] [Related]
5. Five-year incidence of age-related maculopathy: the Visual Impairment Project.
Mukesh BN; Dimitrov PN; Leikin S; Wang JJ; Mitchell P; McCarty CA; Taylor HR
Ophthalmology; 2004 Jun; 111(6):1176-82. PubMed ID: 15177968
[TBL] [Abstract][Full Text] [Related]
6. 14-year incidence, progression, and visual morbidity of age-related maculopathy: the Copenhagen City Eye Study.
Buch H; Nielsen NV; Vinding T; Jensen GB; Prause JU; la Cour M
Ophthalmology; 2005 May; 112(5):787-98. PubMed ID: 15878058
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents.
Tomany SC; Wang JJ; Van Leeuwen R; Klein R; Mitchell P; Vingerling JR; Klein BE; Smith W; De Jong PT
Ophthalmology; 2004 Jul; 111(7):1280-7. PubMed ID: 15234127
[TBL] [Abstract][Full Text] [Related]
8. Retinal vessel diameters and the risk of incident age-related macular disease: the Rotterdam Study.
Ikram MK; van Leeuwen R; Vingerling JR; Hofman A; de Jong PT
Ophthalmology; 2005 Apr; 112(4):548-52. PubMed ID: 15808242
[TBL] [Abstract][Full Text] [Related]
9. The three-year incidence of age-related macular degeneration: the "Pathologies Oculaires Liées à l'Age" (POLA) prospective study.
Delcourt C; Lacroux A; Carrière I;
Am J Ophthalmol; 2005 Nov; 140(5):924-6. PubMed ID: 16310477
[TBL] [Abstract][Full Text] [Related]
10. Statins and the long-term risk of incident age-related macular degeneration: the Blue Mountains Eye Study.
Tan JS; Mitchell P; Rochtchina E; Wang JJ
Am J Ophthalmol; 2007 Apr; 143(4):685-7. PubMed ID: 17386278
[TBL] [Abstract][Full Text] [Related]
11. Age-related macular degeneration and risk of coronary heart disease: the Atherosclerosis Risk in Communities Study.
Wong TY; Tikellis G; Sun C; Klein R; Couper DJ; Sharrett AR
Ophthalmology; 2007 Jan; 114(1):86-91. PubMed ID: 17198851
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for choroidal neovascularization and geographic atrophy in the complications of age-related macular degeneration prevention trial.
Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group
Ophthalmology; 2008 Sep; 115(9):1474-9, 1479.e1-6. PubMed ID: 18502512
[TBL] [Abstract][Full Text] [Related]
13. Retinal vessel signs and 10-year incident age-related maculopathy: the Blue Mountains Eye Study.
Liew G; Kaushik S; Rochtchina E; Tan AG; Mitchell P; Wang JJ
Ophthalmology; 2006 Sep; 113(9):1481-7. PubMed ID: 16828507
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of progression of early age-related macular degeneration: the cardiovascular health and age-related maculopathy study.
Tikellis G; Robman LD; Dimitrov P; Nicolas C; McCarty CA; Guymer RH
Eye (Lond); 2007 Feb; 21(2):169-76. PubMed ID: 16732219
[TBL] [Abstract][Full Text] [Related]
15. The epidemiology of age-related macular degeneration.
Klein R; Peto T; Bird A; Vannewkirk MR
Am J Ophthalmol; 2004 Mar; 137(3):486-95. PubMed ID: 15013873
[TBL] [Abstract][Full Text] [Related]
16. Alcohol consumption and the 5-year incidence of age-related maculopathy: the Beaver Dam eye study.
Moss SE; Klein R; Klein BE; Jensen SC; Meuer SM
Ophthalmology; 1998 May; 105(5):789-94. PubMed ID: 9593377
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of highly myopic eyes: the Beijing Eye Study.
Xu L; Li Y; Wang S; Wang Y; Wang Y; Jonas JB
Ophthalmology; 2007 Jan; 114(1):121-6. PubMed ID: 17070594
[TBL] [Abstract][Full Text] [Related]
18. Is medication use associated with the incidence of early age-related maculopathy? Pooled findings from 3 continents.
van Leeuwen R; Tomany SC; Wang JJ; Klein R; Mitchell P; Hofman A; Klein BE; Vingerling JR; Cumming RG; de Jong PT
Ophthalmology; 2004 Jun; 111(6):1169-75. PubMed ID: 15177967
[TBL] [Abstract][Full Text] [Related]
19. Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye Study cohort.
Wang JJ; Foran S; Smith W; Mitchell P
Arch Ophthalmol; 2003 May; 121(5):658-63. PubMed ID: 12742843
[TBL] [Abstract][Full Text] [Related]
20. Chronic kidney disease, early age-related macular degeneration, and peripheral retinal drusen.
Choi J; Moon JW; Shin HJ
Ophthalmic Epidemiol; 2011 Dec; 18(6):259-63. PubMed ID: 22053834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
